"Heterografts" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tissues, cells or organs transplanted between animals of different species.
| Descriptor ID |
D064593
|
| MeSH Number(s) |
A01.941.875
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Heterografts".
Below are MeSH descriptors whose meaning is more specific than "Heterografts".
This graph shows the total number of publications written about "Heterografts" by people in this website by year, and whether "Heterografts" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 8 | 8 |
| 2014 | 0 | 15 | 15 |
| 2015 | 0 | 13 | 13 |
| 2016 | 1 | 6 | 7 |
| 2017 | 0 | 15 | 15 |
| 2018 | 1 | 8 | 9 |
| 2019 | 0 | 6 | 6 |
| 2020 | 1 | 8 | 9 |
| 2021 | 2 | 10 | 12 |
| 2022 | 0 | 6 | 6 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 4 | 4 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heterografts" by people in Profiles.
-
Public Health, Xenozoonosis, and the Right to Withdraw from Long Term Xenotransplant Biosurveillance. New Bioeth. 2025 Jun-Dec; 31(2-4):75-85.
-
The promise of xenotransplantation: a challenge. J Med Ethics. 2025 Jul 23; 51(8):512-515.
-
A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis. Cancer Res. 2024 07 02; 84(13):2060-2072.
-
The Power and Promise of Patient-Derived Xenografts of Human Breast Cancer. Cold Spring Harb Perspect Med. 2024 04 01; 14(4).
-
Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs). Pathol Res Pract. 2024 Mar; 255:155163.
-
Xenograft recipients and the right to withdraw from a clinical trial. Bioethics. 2024 05; 38(4):308-315.
-
Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy. J Immunother Cancer. 2023 04; 11(4).
-
In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts. J Mammary Gland Biol Neoplasia. 2022 06; 27(2):211-230.
-
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat Cancer. 2022 02; 3(2):232-250.
-
NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer. Sci Rep. 2022 02 04; 12(1):1972.